Close Menu

NEW YORK (GenomeWeb) — SeqWell and Gencove said today that they have agreed to combine certain of their respective technologies into a single product for low-pass whole-genome sequencing and genotype imputation.

Under the terms of the deal, the companies will join SeqWell's PlexWell multiplexed next-generation sequencing library preparation technology with Gencove's imputation and analysis software. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.